Search   
MSDS  : L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrr olidinyl)carbonyl)ami no)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-
CAS  : 24729-96-2
SYNONYMS  : * 7(S)-Chloro-7-deoxylincomycin 2-phosphate * Cleocin phosphate * Clindamycin phosphate * Clindamycin 2-phosphate * Dalacin P * U 28508
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : GF2625000
CHEMICAL NAME : L-threo-alpha-D-galacto-Octapyranoside, methyl
7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrr
olidinyl)carbonyl)ami no)-1-thio-, 2-(dihydrogen
phosphate), (2S-trans)-
CAS REGISTRY NUMBER : 24729-96-2
LAST UPDATED : 199707
DATA ITEMS CITED : 19
MOLECULAR FORMULA : C18-H34-Cl-N2-O8-P-S
MOLECULAR WEIGHT : 505.02
WISWESSER LINE NOTATION : T6OTJ BS1 COPQQO DQ EQ FYYG1&MV- BT5NTJ A1 D3
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* 7(S)-Chloro-7-deoxylincomycin 2-phosphate
* Cleocin phosphate
* Clindamycin phosphate
* Clindamycin 2-phosphate
* Dalacin P
* U 28508

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 12 mg/kg
TOXIC EFFECTS :
Cardiac - pulse rate increase, without fall in BP
Cardiac - other changes
Vascular - BP lowering not characterized in autonomic section
REFERENCE :
SMJOAV Southern Medical Journal. (Southern Medical Assoc., POB 2446,
Birmingham, AL 35205) V.1- 1908- Volume(issue)/page/year: 75,768,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1832 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
27,308,1974

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 745 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3861 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 321 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka
Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
Volume(issue)/page/year: 25,691,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2539 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 784 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DECRDP Drugs under Experimental and Clinical Research. (Bioscience
Ediprint, Blvd. James-Fazy 13, 1201 Geneva 1, Switzerland) V.1- 1977-
Volume(issue)/page/year: 3,79,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1036 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 820 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 14,484,1983

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 700 mg/kg
SEX/DURATION : female 9-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1697,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 1400 mg/kg
SEX/DURATION : female 9-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1697,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE : 700 mg/kg
SEX/DURATION : female 9-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1710,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE : 700 mg/kg
SEX/DURATION : female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1697,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE : 2800 mg/kg
SEX/DURATION : female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1697,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE : 700 mg/kg
SEX/DURATION : female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1710,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE : 1400 mg/kg
SEX/DURATION : female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1710,1973

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X3829
No. of Facilities: 212 (estimated)
No. of Industries: 1
No. of Occupations: 5
No. of Employees: 10980 (estimated)
No. of Female Employees: 8092 (estimated)


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
7-Octen-1-ol, 3,7-dimethyl- 141-25-3
7-Octen-1-ol, 3,7-dimethyl-, (S)- 6812-78-8
7-Octen-2-ol, 2,6-dimethyl- 18479-58-8
6-Octen-1-ol, 3,7-dimethyl-, acetate 150-84-5
6-Octen-4-ol, 2,7-dimethyl-, acetate 102-58-9
7-Octen-1-ol, 3,7-dimethyl-, acetate 141-11-7
6-Octen-1-ol, 3,7-dimethyl-, butyrate 141-16-2
6-Octen-1-ol, 3,7-dimethyl-, crotonate 68039-38-3
Nortoxiferinium, N,N'-diallyl-, dichloride 15180-03-7
6-Octen-1-ol, 3,7-dimethyl-, formate 105-85-1
7-Octen-2-ol, 2,6-dimethyl-8-(1H-indol-1-yl)- 68527-79-7
7-Octen-1-ol, 3,7-dimethyl-, propionate 105-89-5
1-Octen-3-ol, 3-methyl- 24089-00-7
7-Octen-2-ol, 2-methyl-6-methylene- 543-39-5
7-Octen-2-ol, 2-methyl-6-methylene-, acetate 1118-39-4
1-Octen-2-one,4-((dimethylamino)methyl)-4-methyl-1-phenyl-,hydrochloride 1118-39-4
6-Octen-1-yn-3-ol, 3,7-dimethyl-, acetate 29171-21-9
6-Octen-4-yn-2-ol, 1-(dimethylamino)-6-ethyl-,hydrochloride 25708-11-6
d-Octopine, nitrosated 104639-48-7
1-alpha-H,5-alpha-H-Nortropane,8-benzyl-3-alpha-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten- 5-yl)oxy)-, maleate (1:1) 1630-89-3
D-erythro-D-galacto-Octopyranoside,2-hydroxyethyl-6,8-dideoxy-7-O-methyl-6-(1-methyl-L-2-pyrrolidinecarboxamido)-1-thio-, monosalicylate(ester), alpha- 2520-21-0
L-threo-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha- 18323-44-9
D-erythro-D-galacto-Octopyranoside, methyl7-(S)-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, hydrochloride,trans-alpha- 17431-55-9
L-threo-alpha-D-galacto-Octapyranoside, methyl7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)ami no)-1-thio-, 2-(dihydrogenphosphate), (2S-trans)- 24729-96-2
L-threo-alpha-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-(((4-pentyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-,monohydrochloride, (2S-cis)- 33054-87-4
D-erythro-alpha-D-galacto-Octopyranoside, methyl6,8-dideoxy-7-O-methyl-6-(((1-methyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (S)- 75007-09-9
D-erythro-D-Galacto-octopyranoside,methyl-6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha- 154-21-2
D-erythro-D-galacto-Octopyranoside, methyl6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride,trans-alpha- 859-18-7
D-erythro-D-Galacto-octopyranoside, methyl6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride,hemihydrate 7179-49-9
Octyl alcohol 111-87-5
1-alpha-H,5-alpha-H-Nortropane-2-beta-carboxylicacid, 3-beta-hydroxy-, methyl ester, benzoate (ester) 18717-72-1
Octyl alcohol, mixed isomers 29063-28-3
sec-Octyl alcohol 25339-16-6
Octylamine, acetate 2016-40-2
Octylamine, N-(2-(diethylamino)ethyl)-N-(2-pyridyl)-,trioxalate 101858-34-8
Octylamine,N-(3-(dimethylamino)propyl)-N-(2-pyridyl)- 25295-39-0
Octylamine, N,N-dimethyl-, hydrochloride 2016-50-4
1-Octylamine,N,N-dimethyl-5-imino-4-isopropyl-4-naphthyl- 13362-85-1
Octylamine, 4-ethyl-1-methyl- 10024-78-9
Octylamine, 8-fluoro- 593-16-8
Octylamine, N-methyl-N-nitroso- 34423-54-6
1-alpha-H,5-alpha-H-Nortropane, 3-alpha-chloro-,hydrochloride 14379-07-8
Octylamine,N-(2,3,6,7-tetrahydro-1H,5H-benzo(ij)quinolizin-9-yl)-, dihydrochloride 101858-35-9
Octyl ether 629-82-3
Octyl phenol condensed with 1 mole ethylene oxide 629-82-3
Octyl phenol condensed with 3 moles ethylene oxide 629-82-3
Octyl phenol condensed with 16 moles ethylene oxide 9036-19-5
Octyl phenol condensed with 20 moles ehtylene oxide 9036-19-5
2-Octynamide 9036-19-5
5-Octyn-4-amine, 4-ethyl-, hydrochloride 64467-43-2

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net